Literature DB >> 16598466

The antibody response in experimental ocular toxoplasmosis.

Justus G Garweg1, Matthias Boehnke.   

Abstract

BACKGROUND: The dynamics of the humoral immune response in ocular toxoplasmosis (OT) are poorly understood. We therefore investigated this process in a rabbit model of the disease.
MATERIALS AND METHODS: Of 24 infection-naive adult rabbits, 12 were left untreated and 12 were systematically infected with 5,000 tachyzoites of the non-cystforming BK strain of Toxoplasma gondii. Three months later, all rabbits were inoculated transvitreally with 5,000 tachyzoites of Toxoplasma gondii. Paired samples of aqueous humor and serum were analyzed temporally for their total and specific IgG contents.
RESULTS: In infection-naïve rabbits with primary OT, specific IgG reached detectable levels in the inoculated eyes between 5 and 15 days after inoculation. In infection-immunized rabbits with secondary OT, a significant increase in specific IgG was regularly detected after 5 days. The antibody ratio C was diagnostic (> or =3) from day 15 onward in primary OT and from day 21 onward in secondary OT. In the uninfected partner eyes, the antibody ratio C was found sporadically diagnostic from day 15 onward in primary OT, but at no time in secondary OT. Specific IgG persisted both locally and in the serum until the end of the monitoring period (100 days).
CONCLUSION: Our findings relating to the rabbit model of OT reveal three features of clinical relevance: a diagnostic window precedes the establishment of a humoral immune response; specific antibodies persist long after the cessation of disease activity; and in primary OT, the antibody ratio C may also increase in the uninfected partner eye.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16598466     DOI: 10.1007/s00417-006-0274-x

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  54 in total

1.  Reliability of expert interpretation of retinal photographs for the diagnosis of toxoplasma retinochoroiditis.

Authors:  M R Stanford; L Gras; A Wade; R E Gilbert
Journal:  Br J Ophthalmol       Date:  2002-06       Impact factor: 4.638

2.  [Current limits in diagnosis of ocular toxoplasmosis].

Authors:  J G Garweg; P Jacquier; F Flückiger
Journal:  Klin Monbl Augenheilkd       Date:  1998-05       Impact factor: 0.700

3.  Analysis of immunoregulatory cytokines in ocular fluid samples from patients with uveitis.

Authors:  J V Ongkosuwito; E J Feron; C E van Doornik; A Van der Lelij; C B Hoyng; E C La Heij; A Kijlstra
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-12       Impact factor: 4.799

4.  Restricted applicability of the polymerase chain reaction for the diagnosis of ocular toxoplasmosis.

Authors:  J Garweg; M Boehnke; F Koerner
Journal:  Ger J Ophthalmol       Date:  1996-03

5.  Evidence for a compartmentalized B cell response as characterized by IgG epitope specificity in human ocular toxoplasmosis.

Authors:  V N Klaren; R Peek
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

6.  Laboratory tests in uveitis. New developments in the analysis of local antibody production.

Authors:  A Kijlstra; G J van den Horn; L Luyendijk; G S Baarsma; C M Schweitzer; M J Zaal; Z Timmerman; M Beintema; A Rothova
Journal:  Doc Ophthalmol       Date:  1990-10       Impact factor: 2.379

7.  Toxoplasmosis: an epidemiological study.

Authors:  F Jennis
Journal:  Australas Ann Med       Date:  1966-05

8.  Ocular toxoplasmosis after the fifth decade.

Authors:  Pierre Labalette; Laurence Delhaes; Fabrice Margaron; Bernard Fortier; Jean-François Rouland
Journal:  Am J Ophthalmol       Date:  2002-04       Impact factor: 5.258

9.  Diagnostic approaches to severe, atypical toxoplasmosis mimicking acute retinal necrosis.

Authors:  Darius M Moshfeghi; Emilio M Dodds; Cristóbal A Couto; Carmen I Santos; Donald H Nicholson; Careen Y Lowder; Janet L Davis
Journal:  Ophthalmology       Date:  2004-04       Impact factor: 12.079

10.  Antibodies against Toxoplasma gondii in the aqueous humour of patients with active retinochoroiditis.

Authors:  O O Pedersen; A M Lorentzen-Styr
Journal:  Acta Ophthalmol (Copenh)       Date:  1981-10
View more
  6 in total

1.  Anti-retinal autoantibodies in experimental ocular and systemic toxoplasmosis.

Authors:  Justus G Garweg; Yvonne de Kozak; Brigitte Goldenberg; Matthias Boehnke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-12-03       Impact factor: 3.117

2.  Diagnostic approach to ocular toxoplasmosis.

Authors:  Justus G Garweg; Jolanda D F de Groot-Mijnes; Jose G Montoya
Journal:  Ocul Immunol Inflamm       Date:  2011-08       Impact factor: 3.070

3.  Toxoplasma Gondii Infection of Chicken Embryos Causes Retinal Changes and Modulates HSP90B1 Gene Expression: A Promising Ocular Toxoplasmosis Model.

Authors:  Alex M Nasaré; Roberto C Tedesco; Priscila C Cristovam; Marcos A Cenedese; Andrés J Galisteo; Heitor F Andrade; José Álvaro P Gomes; Érik V Guimarães; Helene S Barbosa; Luis G Alonso
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-11-12

4.  Biological Diagnosis of Ocular Toxoplasmosis: a Nine-Year Retrospective Observational Study.

Authors:  Valentin Greigert; Alexander W Pfaff; Arnaud Sauer; Denis Filisetti; Ermanno Candolfi; Odile Villard
Journal:  mSphere       Date:  2019-09-25       Impact factor: 4.389

5.  Risks and Challenges in Interpreting Simultaneous Analyses of Multiple Cytokines.

Authors:  Isabel B Pfister; Souska Zandi; Christin Gerhardt; Jan Spindler; Natalie Reichen; Justus G Garweg
Journal:  Transl Vis Sci Technol       Date:  2020-06-24       Impact factor: 3.283

6.  Wild Rabbit Exposure to Leishmania infantum, Toxoplasma gondii, Anaplasma phagocytophilum and Babesia caballi Evidenced by Serum and Aqueous Humor Antibody Detection.

Authors:  Labrini V Athanasiou; Eleni G Katsogiannou; Constantina N Tsokana; Sofia G Boutsini; Marina G Bisia; Vasileios G Papatsiros
Journal:  Microorganisms       Date:  2021-12-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.